Breaching The Blood/Brain Barrier To Improve Treatment For Neurodegenerative Diseases

Stuart SchlossmanMisc. MS Related

June 8, 2010

The University of South Florida’s Department of Neurosurgery and Brain Repair has been granted a patent for a cell transplantation procedure combining human umbilical cord blood (HUCB) cells and a sugar-alcohol compound called “mannitol” that may make a big difference in treating life-threatening neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis and stroke, among others. 

The technology administers the neuroprotective effect of umbilical cord blood cells along with mannitol to permeabilize the blood-brain barrier, allowing for the increased entry of therapeutic growth factors. Saneron CCEL Therapeutics, Inc., a biotechnology R&D USF spin-out company located at the Tampa Bay Technology Incubator, has licensed the technology. 



click to continue

*

*

***********************************************************
Providing You with ‘MS Views and News’is what we do
Keep Informed and uptodate with information concerning
 Multiple Sclerosis when registered at
(This will take 20-25 seconds and will empower you
 with informaton and learning)
Thank you for allowing me to help to keep you informed
****************************************************************
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews